Ultrasensitive blood test predicts head and neck cancer relapse months earlier

Дата публикации: 10-06-2026 18:00:03

A new study by investigators from Mass General Brigham Cancer Institute has found that an ultrasensitive blood test called HPV-DeepSeek could help identify which people with HPV-associated head and neck cancer still had cancer cells in their bodies after surgery and may benefit the most from additional treatments. The results are published in Science Translational Medicine.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Blood test finds hidden pancreatic cancer after treatment	5	8	30-06-2026
2	New brush test detects oral cancer in one hour	7	8	06-07-2026
3	Is Antigen-Specific Immunotherapy a New Frontier in HPV-Initiated Head and Neck Cancer?	0	10.94	17-09-2026
4	Novel biomarker research offers new hope in the fight against colorectal cancer	7	8	06-07-2026
5	Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery	0	5	06-07-2026
6	Natera’s Steve Chapman Wants to See Cancer Coming	0	6.98	05-08-2026
7	Immunotherapy in Head and Neck Squamous Cell Carcinoma With PD-L1 Combined Positive Score of Less Than 1	0	12.19	17-09-2026
8	‘Liquid biopsy’ tech contributes to successful clinical trial for detecting breast cancer recurrence	0	6.61	29-07-2020
9	Researchers expand plasmonic liquid biopsy platform to early-stage colorectal cancer	5	7	09-07-2026
10	A single blood test could spot multiple cancers early, saving lives	0	9.73	16-02-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: medicalxpress.com.